POLYMORPHIC FORM OF TG02 FOR TREATING CANCER
The present disclosure provides crystalline polymorphic forms of TG02 free base and TG02 acid addition salts, pharmaceutical compositions comprising crystalline polymorphic forms of TG02 free base and TG02 acid addition salts, and methods of treating cancer and other diseases in a patient with cryst...
Saved in:
Main Authors | , |
---|---|
Format | Patent |
Language | English |
Published |
01.08.2024
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The present disclosure provides crystalline polymorphic forms of TG02 free base and TG02 acid addition salts, pharmaceutical compositions comprising crystalline polymorphic forms of TG02 free base and TG02 acid addition salts, and methods of treating cancer and other diseases in a patient with crystalline polymorphic forms of TG02 free base and TG02 acid addition salts. |
---|---|
Bibliography: | Application Number: US202318530745 |